Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Seelos Therapeutics (SEEL) just unveiled an update.
Seelos Therapeutics, Inc. has announced an upcoming reverse split of its common stock, aiming to make a strategic move in the market. This decision is detailed in their latest press release, which investors might find of significant interest, as it could affect stock value and ownership.
For a thorough assessment of SEEL stock, go to TipRanks’ Stock Analysis page.